INBX US Equity

Inhibrx Biosciences, Inc.

Health Care · Biological Products, (No Diagnostic Substances) · CIK 2007919 · FY ends Dec 31

$101.48

+6.86 (+7.25%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Documents

2 of 2 10-Ks readable here

Period end	Filed	Form	Read here	EDGAR
2025-12-31	2026-03-19	10-K	read · risk factors · MD&A	index · original · 0002007919-26-000006
2024-12-31	2025-03-17	10-K	read · risk factors · MD&A	index · original · 0002007919-25-000019

72 captions · 2 filings

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

72 captions across 2 filings4 added7 dropped61 in every year2 of 2 10-Ks on file are cached here

Risk-factor caption

2024

2025

Years

●

2 rw

●

The filer's own 10-K text · 2 filings read

Rows are the filing's own headings, verbatim — nothing is summarized or generated.

A blank cell means the filer did not print that heading that year — not that the risk ended.

Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.

2 filings measured

Descriptive and within-name: this is what changed in the wording of one firm's own filings.

Filed	Period end	Document words	Item 1A words	Negation / 10k	Hedging / 10k	Filing
2025-03-17	2024-12-31	83,478	39,216	69.96	199.93	read · EDGAR ↗
2026-03-19	2025-12-31	87,409	42,268	69.44	205.13	read · EDGAR ↗

The filer's own 10-K text · 2 filings measured

House wordlists, not a licensed dictionary and not tuned against returns.

9 negation words · 40 hedging words — hover to read both lists.

Each point sits at its filing date and is held flat until the next filing.